Lataa...
PDE4 inhibitors: current status
Phosphodiesterase4 inhibitors are currently under development for the treatment of respiratory diseases including asthma and chronic obstructive pulmonary disease. The rationale for the development of this drug class stems from our understanding of the role of PDE4 in suppressing the function of a r...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2567892/ https://ncbi.nlm.nih.gov/pubmed/18660825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjp.2008.307 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|